Clinical Trial Update: Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD) [NA]

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating the effect of Vyvanse (lisdexamfetamine) on sleep in children aged 6-12 with ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Clinical Study Centers, LLC | Conditions: Attention Deficit Hyperactivity Disorder, Sleep | NA | Status: COMPLETED